November 19, 2024 · STOCK Act disclosure
Representative Michael T. McCaul (Republican-TX) sold Neurocrine Biosciences, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on November 19, 2024 and was disclosed on December 16, 2024 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.